ASSOCIATION OF SMOKING AND PROSTATE CANCER: A 10 YEARS SYSTEMATIC REVIEW
DOI:
https://doi.org/10.61841/vmmj7884Keywords:
Prostate cancer, smoking, carcinogen.Abstract
Background: Prostate cancer (PCa) is the second most commonly diagnosed cancer and the fifth leading cause of cancer death among males, with an estimated 1.4 million new cases and 375 000 deaths worldwide in 2020, accounting for 7.3% and 3.8% of all cancers diagnosed, respectively. Various endogenous and exogenous risk factors for PCa have been discussed for decades. Several factors have been identified to be associated with an increased risk of PCa, for instance, family history, elevated hormone levels, black ethnicity, and high alcohol consumption.
The aim: This study aims to show about association of smoking and prostate cancer.
Methods: By comparing itself to the standards set by the Preferred Reporting Items for Systematic Review and MetaAnalysis (PRISMA) 2020, this study was able to show that it met all of the requirements. So, the experts were able to make sure that the study was as up-to-date as it was possible to be. For this search approach, publications that came out between 2014 and 2024 were taken into account. Several different online reference sources, like Pubmed and SagePub, were used to do this. It was decided not to take into account review pieces, works that had already been published, or works that were only half done.
Result: In the PubMed database, the results of our search brought up 30 articles, whereas the results of our search on SagePub brought up 55 articles. The results of the search conducted for the last year of 2014 yielded a total 13 articles for PubMed and 23 articles for SagePub. The result from title screening, a total 10 articles for PubMed and 15 articles for SagePub. In the end, we compiled a total of 10 papers. We included five research that met the criteria.
Conclusion: Regarding smoking, burning tobacco and inhaling the smoke is considered a significant risk factor or direct cause of cancer, tumor lesions, and a well-known chemical carcinogen.
References
Wilson KM, Markt SC, Fang F, Nordenvall C, Rider JR, Ye W, et al. Snus use, smoking and survival among prostate cancer patients. Int J Cancer. 2016;139(12):2753–9.
Al-Fayez S, El-Metwally A. Cigarette smoking and prostate cancer: A systematic review and meta-analysis of prospective cohort studies. Tob Induc Dis. 2023;21:1–12.
D Mazhar JW. Prostate Cancer Prostate Cancer. Abeloff’s Clin Oncol 5/e [Internet]. 2015;8(2):938–44. Available from: http://dx.doi.org/10.1016/B978-1-4557-2865-7.00084-9
Yang X, Chen H, Zhang S, Chen X, Sheng Y, Pang J. Association of cigarette smoking habits with the risk of prostate cancer: a systematic review and meta-analysis. BMC Public Health [Internet]. 2023;23(1):1–14. Available from: https://doi.org/10.1186/s12889-023-16085-w
Ballard C and K. 乳鼠心肌提取 HHS Public Access. Curr Emerg Hosp Med Rep. 2019;7(3):127–34.
Jiménez-Mendoza E, Vázquez-Salas RA, Barrientos-Gutierrez T, Reynales-Shigematsu LM, Labra-Salgado IR, Manzanilla-García HA, et al. Smoking and prostate cancer: A life course analysis. BMC Cancer. 2018;18(1):1– 11.
Ho T, Howard LE, Vidal AC, Gerber L, Moreira D, McKeever M, et al. Smoking and risk of low- and highgrade prostate cancer: Results from the REDUCE study. Clin Cancer Res. 2014;20(20):5331–8.
Moreira DM, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, et al. Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy: Results from the SEARCH database. Cancer. 2014;120(2):197–204.
Kao YH, Lin WT, Thomas CL, Lin HY, Tseng TS. Association between smoking and neutrophil to lymphocyte ratio among prostate cancer survivors: The national health and nutrition examination survey. Transl Cancer Res. 2019;8(1):S346–54.
Foerster B, Pozo C, Abufaraj M, Mari A, Kimura S, D’Andrea D, et al. Association of smoking status with recurrence,metastasis, and mortality among patients with localized prostate cancer undergoing prostatectomy or radiotherapy: A systematic review and meta-analysis. JAMA Oncol. 2018;4(7):953–61.
Kumar R, Matulewicz R, Mari A, Moschini M, Ghodoussipour S, Pradere B, et al. Impact of smoking on urologic cancers: a snapshot of current evidence. World J Urol [Internet]. 2023;41(6):1473–9. Available from: https://doi.org/10.1007/s00345-023-04406-y
Sekhoacha M, Riet K, Motloung P, Gumenku L, Adegoke A, Mashele S. Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches. Molecules. 2022;27(17):1–33.
Zhang H, Huang D, Zhang Y, Wang X, Wu J, Hong D. Global burden of prostate cancer attributable to smoking among males in 204 countries and territories, 1990–2019. BMC Cancer [Internet]. 2023;23(1):1–14. Available from: https://doi.org/10.1186/s12885-023-10552-8
Villers A, Grosclaude P. Épidémiologie du cancer de la prostate. Article de revue. Med Nucl. 2008;32(1):2–4.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
